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Abstract Furin, a member of the yeast Kex2 endoprotease 
family, converts a number of proproteins to their active forms. 
The liver produces a number of proproteins having a furin-
cleavable site; thus, furin may be involved in growth and 
differentiation both in the partially hepatectomized liver and in 
primary cultured hepatocytes. Furin mRNA levels are elevated in 
tissues regenerated from partially hepatectomized rat liver. In 
primary culture of rat hepatocytes, furin expression increases 
gradually with time, and its expression is greatly enhanced by 
transforming growth factor ßl, whose processing from the 
precursor requires cleavage by furin. Thus, we suggest that the 
regeneration and differentiation of hepatocytes is dependent upon 
the co-elevation of furin and transforming growth factor ßl 
mRNAs. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Furin, a proprotein-processing enzyme, is a member of the 
yeast Kex2 family of endoproteases that contain a subtilisin-
like serine-protease domain as an active site [1,2]. This enzyme 
is distributed more or less in virtually all tissues, and high 
expression is observed in the normal liver [3]. Furin cleaves 
the carboxy-terminus of the unique consensus sequence 
-Arg^-X^-Lys/Arg^-Arg-1 [RX(K/R)R]. The most essen-
tial residues of this sequence are the Args at the —1 and —4 
positions. However, Arg~6 can replace Arg - 4 , although this 
renders the cleavage of RXXX(K/R)R by furin less efficient 
[4]; thus, for cleavage to occur properly, more basic amino 
acids are required ahead of the general cleavage site of most 
propeptide hormones, -(Lys/Arg)_2-Arg_1 [2]. A number of 
proproteins are known to contain this furin-cleavable motif 
[1]: growth factor precursors including platelet-derived 
growth factor (PDGF), transforming growth factor ß 
(TGFß), activin A, and insulin-like growth factor-1 (IGF-1); 
some growth factor proreceptors such as insulin receptor, 
IGF-1 receptor, and hepatocyte growth factor (HGF) recep-
tor (oncoprotein MET); matrix metalloproteinases (MMP) 
such as stromelysin-3 and membrane-type MMP-1; adhesion 
molecules such as the cadherin family and integrins cx3 and 
a6 ; and many plasma proteins including albumin, coagulation 
factors VII, IX, and X, and von Willebrand factor, and plas-
minogen activator-1. The liver, including mesenchymal and 
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non-mesenchymal cells, contains these proproteins as listed 
in Table 1. 
Previously, we found that furin is highly expressed during 
the growth state of many cell types. When furin is highly 
expressed in well-differentiated pancreatic ß cell line MIN6 
cells, the ß cell-specific differentiated characteristics such as 
insulin content, expression of prohormone convertases PC2 
and PC3, and glucose-regulated insulin secretion, diminish 
[5]. A ß cell line, such as MIN6 and ßHC9, with a higher 
level of insulin content and secretory granules expresses a 
low level of furin, and exhibits slower cell growth; whereas 
a ß cell line with less-differentiated characteristics, such as 
ßTC3 and RINm5F, expresses a high level of furin and grows 
much faster than differentiated ß cell lines [5,6]. Furin is 
highly expressed in whole rat islets during the perinatal peri-
od, when islet cell replication is most extensive, expression 
then decreases as development continues toward the adult 
stage [7]. We also found in the adult rat gastric gland furin-
positive cells layered along the proliferative cell zone. By using 
a gastric surface mucosal cell line, GSM06, we demonstrated 
that when furin expression is suppressed by its antisense oli-
gonucleotide, cell growth is retarded and expression of the 
differentiated characteristics, such as the appearance of peri-
odic acid-Schiff-positive materials, is enhanced [8]. In cardiac 
myocytes, furin was strongly immunostained when the cells 
underwent hypertrophic growth by stretching [9]. When we 
infarcted the hearts of rats by ligation of the left descending 
coronary artery, we found that furin was highly expressed 
along the cells adjacent to the infarcted area [10]. Thus, we 
propose that furin is expressed when dividing cells undergo 
proliferation and non-dividing cells experience hypertrophic 
growth. 
The liver has an enormous capacity to regenerate following 
either partial hepatectomy or massive liver damage by severe 
hepatitis [11,12]. During its regenerative growth, a number of 
growth factors and growth-related proteins are expressed in a 
cascade fashion. After regeneration, the liver produces a mas-
sive amount of plasma proteins to maintain homeostasis. As 
listed in Table 1, many proproteins produced in the liver 
contain a furin-specific cleavage site. However, some growth 
factors and proreceptors, such as PDGF, IGF-1, and c-Met, 
induce hepatocytic growth, whereas others, such as TGFß and 
activin A, induce cell differentiation. As for plasma proteins, 
some proproteins including complements are produced in the 
acute-phase response to injury, while others such as albumin 
are produced primarily from the normal-state liver. However, 
we do not yet know whether furin expressed for the conver-
sion of proproteins derives from the growing or the differ-
entiated state of the hepatocytes. The present study demon-
strates changes in the expression of furin and its substrate 
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T G F ß after a partial hepatectomy and during the primary 
culturing of the hepatocytes. 
2. Materials and methods 
2.1. Materials 
Recombinant TGFßl was obtained from King Jyozo (Himeji, Ja-
pan), EGF from Collaborative Biomedicai Products (Bedford, MA, 
USA). Male Wistar rats (150-200 g) were purchased from Imai Ex-
perimental Animal Farm (Saitama, Japan). 
2.2. Surgical procedures 
Rats were maintained under controlled light (7:00 to 19:00 h) with 
food and water provided ad libitum. Partial (70%) hepatectomy was 
performed under anesthesia with diethyl ether, as described previously 
[13]. After opening the peritoneal cavity, the left lateral and left me-
dian lobes were excised from the liver. Control operations were per-
formed using an identical procedure without excision of any liver 
tissue. At an indicated time after the operation, the rats were killed 
and their livers were removed for RNA isolation. 
2.3. Hepatocyte isolation and culture 
Hepatocytes were prepared by perfusion of the liver with collagen-
ase [14]. Cells were plated close to confluence (6-7 X 104/cm2) on a 
90-mm collagen-coated dish in Williams' E medium, containing 5% 
fetal bovine serum, 10 nM insulin, 1 nM dexamethasone, streptomy-
cin and penicillin. After 3 h, the cells were washed with phosphate-
buffered saline, then incubated in fresh, serum-free Williams' E me-
dium, containing 0.1% bovine serum albumin (BSA) with EGF 
(10 ng/ml) or TGFßl (usually at 100 pM; in other cases at an in-
dicated concentration). Culture media were replaced every 24 h. 
2.4. RNA extraction and hybridization 
Total RNA was extracted from primary cultured hepatocytes or 
Table 1 
A list of liver-produced proproteins with a furin-cleavable site 
Proprotein Propeptide Bioactive peptide 
- 6 - 4 - 1 +1 
Growth factors 
PDGF-A 
PDGF-B 
IGF-1 
TGF-ß 
Activin A 
PTHrP 
Plasma proteins 
Albumin 
Factor VII 
Factor IX 
Factor X 
von Willebrand factor 
Tissue-type plasminogen activator 
Prothrombin 
Protein С 
Matrix metalloproteinases (MMP) 
Stromelysin-3 
Membrane-type MMP-1 
Adhesion molecules 
E-cadherin 
Integrin a3 H-L chain 
Integrin аб H-L chain 
Complements 
Сз β-α chains 
C4 β-α chains 
C4 α-γ chains 
C5 β-α chains 
Pro-receptors 
Insulin receptor α-β chains 
HGF receptor (c-Met) α-β chains 
-K 
-E 
-A 
-Q 
-E 
-V 
-A 
-A 
-G 
-S 
-I 
-A 
-M 
-G 
E 
-S 
-R 
-T 
-c 
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-P 
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DTE-
FVL-
YAI-
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A furin-cleavable consensus sequence is Arg 4-X-(Lys/Arg) 2-Arg λ. Albumin does not possess Arg 4, but instead possess Arg e . Basic residues 
from —1 to —6 positions are written in bold. 
partially hepatectomized liver with TRIzol reagent (Life Technologies, 
Grand Island, NY, USA). For Northern blot analysis, total RNA 
(10 μg) was heat-denatured and electrophoresed on a 1% agarose 
gel, then transferred to a nylon membrane (Hybond-N, Amersham 
Japan, Tokyo, Japan). Hybridization was performed in a solution 
consisting of 5 X SSPE (20 X SSPE = 3.0 M NaCl, 200 mM NaH2P04 , 
20 mM EDTA, pH 7.4), lOxDenhardt's reagent (0.2% Ficoll, 0.2% 
polyvinylpyrrolidone, 0.2% BSA), 50% formamide, 1.4% sodium do-
decyl sulfate (SDS), and 0.1 mg/ml salmon sperm DNA with either a 
mouse furin cDNA probe (a 924-bp fragment cut with BamHl [5]) or 
a rat TGFßl cDNA probe (a 490-bp fragment cut with EcoRl and 
Bgh [15]), labeled with [a-32P]dCTP, using a redi prime random prim-
er labeling kit (Amersham Japan, Tokyo). After washing, the mem-
brane was exposed to X-ray film with an intensifying screen at —80°C. 
3. Results 
3.1. Furin expression after partial hepatectomy 
Total R N A derived from the remaining liver after the par-
tial hepatectomy or after the control operation was subjected 
to Nor thern blot analysis for furin expression. After a control 
operation, furin m R N A levels remained relatively constant up 
to 168 h (7 days) (Fig. 1A); however, after partial hepatec-
tomy, furin expression decreased at 3-6 h, returned to control 
levels at 12-18 h, then gradually increased from 24-168 h 
(Fig. IB). This decrease of furin m R N A was confirmed by a 
total of eight experiments. Furthermore, 18S and 28S riboso-
mal R N A s were equally stained with ethidium bromide at 
each point (Fig. 1С). Because the proliferation of hepatocytes 
is maximal 24 h after partial hepatectomy, 3-6-h points are in 
the middle of the G l phase of the cell cycle [11]. At this phase, 
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Fig. 3. Northern blot analyses of TGFßl mRNAs after partial hep-
atectomy. A: TGFßl mRNAs from control-operated livers. B: 
TGFßl mRNAs from the partially hepatectomized liver. Time (h) 
after the operation is indicated at the top of the panel. The arrow-
head indicates 18S rRNA. The size of TGFßl mRNA is approxi-
mately 2.5 kb. 
Fig. 1. Northern blot analyses of furin mRNAs after partial hepa-
tectomy. A: Furin mRNAs from control-operated livers. B: Furin 
mRNAs from the partially hepatectomized liver. Time (h) after the 
operation is indicated at the top of the panel. The arrowhead indi-
cates 28S rRNA. The size of furin mRNA is approximately 4.5 kb. 
C: 18S and 28S rRNA bands stained with ethidium bromide. 
furin was under-expressed in the partially resected liver. Be-
cause furin mRNA levels became elevated toward the 168-h 
point, furin may be involved in the production of proproteins 
related to cell differentiation. 
3.2. Furin expression in primary cultured hepatocytes 
The gene expression pattern of a primary culture of hepa-
tocytes in the presence of a cocktail of insulin, glucocorticoid, 
and EGF roughly simulates that of partially resected liver 
[16]. In the presence of 10 ng/ml EGF, hepatocytes initially 
grow, then display differentiated features. Furin mRNA was 
elevated approaching the 72-h point post culture (Fig. 2A). 
Furin is known to convert pro-TGFß to its active form [17], 
which then induces a differentiated state of hepatocytes. When 
TGFß (final 100 pM) was further added to the culture me-
dium, furin mRNA levels were markedly elevated, even at the 
24-h point, increasing up to 72 h post culture (Fig. 2B). This 
furin expression was TGFßl dose-dependent up to 300 pM 
(Fig. 2C), and the effect was significant at concentrations 
greater than 100 pM TGFßl. Thus, TGFß is a strong inducer 
of furin in hepatocytes. 
3.3. TGFßl expression after partial hepatectomy 
When furin is expressed, its substrate proproteins may be 
co-expressed. After partial hepatectomy, furin expression in-
creased up to the 168-h point, as already shown in Fig. IB; 
likewise, TGFßl mRNA expression increased toward the 
168-h point in partially hepatectomized rat livers (Fig. 3B), 
but stayed at the same low level in the control rat livers (Fig. 
ЗА). Thus, although the increase of furin mRNA occurred 
earlier than did that of TGFßl mRNA, both furin and 
TGFß mRNAs co-elevated after partial hepatectomy. 
3.4. TGFßl expression in primary cultured hepatocytes 
In the primary culturing of hepatocytes using EGF, TGFßl 
expression was only faintly visible at the 72-h point (Fig. 4A). 
Adding TGFßl to the culture resulted in increased levels of 
TGFßl mRNA expression at the 72-h point (Fig. 4B), similar 
to the furin mRNA expression levels (Fig. 2B). Also, TGFßl 
expression was TGFßl dose-dependent up to 300 pM (Fig. 
4C), and the TGFßl effect was noted above 100 pM TGFßl. 
Thus, TGFßl and furin mRNAs were co-elevated in partially 
hepatectomized liver as well as in primary cultured hepato-
cytes. 
4. Discussion 
Fig. 2. Northern blot analyses of furin mRNAs in primary cultured 
hepatocytes. A: Furin mRNAs after the addition of 10 ng/ml EGF 
to the culture. B: Furin mRNAs after the addition of 10 ng/ml 
EGF and 0.1 nM TGFßl to the culture. Time (h) after the addition 
of EGF or TGFßl is indicated at the top of the panel. C: Expres-
sion of furin mRNAs after the addition of increasing amounts of 
TGFßl for 72 h. TGFßl dosage is indicated at the top of the pan-
el. The arrowhead indicates 28S rRNA. 
This study demonstrated that furin is highly expressed with 
the differentiation of hepatocytes, and its expression is greatly 
enhanced by the same TGFßl that is known to inhibit the 
growth of hepatocytes and to induce their differentiation 
[11,12]. This expression mode of furin is contrary to our pre-
vious findings which detected expression in the growing state 
of pancreatic ß cells, gastric surface mucous cells, and cardiac 
myocytes, as described in Section 1 [5-10]. 
The liver produces a number of proproteins with furin-
cleavable sites, as listed in Table 1 [1]. Some of these, such 
as PDGF, IGF1 and c-Met, are involved in the liver regener-
ation. Because furin expression was high in normal and re-
generated liver and low shortly after partial hepatectomy (Fig. 
1), these proproteins may be cleaved by other Kex2 family 
endoproteases, such as PACE4 [18]. Several bioactive proteins 
are known to induce hepatocyte differentiation in an auto-
crine/paracrine fashion. The most well-known proprotein is 
TGFß, which inhibits the growth and induces the differentia-
tion of hepatocytes [11,12,19]. TGFß is produced as a latent 
12 H. Hoshino et al.lFEBS Letters 419 (1997) 9-12 
furin may activate not only pro-TGFß but also other propro-
teins, such as the plasma proteins, which are instrumental for 
maintaining homeostasis. 
Acknowledgements : This work was supported by grants-in-aid from 
the Ministry of Education, Science, Culture and Sports of Japan. We 
are grateful to Ms. Reiko Uchida for her secretarial assistance. 
References 
Fig. 4. Northern blot analyses of TGFßl mRNAs in primary cul-
tured hepatocytes. A: TGFßl mRNAs after the addition of 10 ng/ 
ml EGF to the culture. B: TGFßl mRNAs after the addition of 
10 ng/ml EGF and 0.1 nM TGFßl to the culture. Time (h) after 
the addition of EGF or TGFßl is indicated at the top of the panel. 
C: Expression of TGFßl mRNAs after the addition of increasing 
amounts of TGFßl over 72 h. TGFßl dosage is indicated at the 
top of the panel. The arrowhead indicates 18S rRNAs. 
form composed of three components : a 25-kDa TGFß dimer, 
a cleaved propeptide dimer non-covalently bound to TGFß, 
and a latent TGFß-binding protein (LTBP). The latent form 
of TGFß requires two processing reactions for maturation: 
first, cleavage of TGFß propeptide precursor by furin [17], 
and second, removal of LTBP possibly by plasmin [20]. 
Thus, furin is required for the activation of pro-TGFß. Fur-
thermore, TGFßl is known to upregulate its own expression 
[21]. Previously, we suggested that whenever furin is ex-
pressed, its substrate proproteins will be co-expressed in the 
same cell; brain natriuretic peptide is one such proprotein that 
is co-expressed with furin in the hypertrophic cardiac myo-
cytes by stretching [9,10]. TGFßl is reported to induce the 
expression of furin in cultured rat synovial cells as early as 
3^18 h after the addition of TGFßl [22]. We also confirmed 
that TGFßl induces the expression of both furin and TGFßl 
in partially hepatectomized liver and also in primary cultured 
hepatocytes. 
In the liver, most of the TGFßl is produced by endothelial 
cells and Kupffer cells, a smaller amount by fat-storing cells 
(also called lipocytes and Ito cells), and a much smaller 
amount by hepatocytes [23]. In our experiments, TGFßl as 
well as furin expression was faintly visible in cultured hepa-
tocytes unless TGFßl had been added to the culture. Since the 
normal liver and regenerated liver express a high level of 
furin, we need to examine whether furin distribution is similar 
to TGFßl distribution in the liver cell types. Although 
TGFßl production was not high, hepatocytes are known to 
continue producing TGFßl over 72 h compared with an 
hourly rise of TGFßl in the other three liver cell types in 
primary culture [23]. In hepatocytes, TGFß induced expres-
sion of furin and additional levels of TGFß. Thus, induced 
9 
[20 
[21 
[22 
[23; 
Nakayama, K. (1997) Biochem. J. 323, 625-635. 
Smeekens, S.P. (1993) Biotechnology 11, 182-186. 
Schalken, J.A., Roebroek, A.J.M., Oomen, P.P.C.A., Wagenaar, 
S.S., Debruyne, F.M.J., Bloemers, H.P.J. and Van de Ven, 
W.J.M. (1987) J. Clin. Invest. 80, 1545-1549. 
Liu, Y.C., Kawagishi, M., Mikayama, Т., Inagaki, Y., Takeuchi, 
T. and Ohashi, H. (1993) Proc. Nati. Acad. Sci. USA 90, 8957-
8961. 
Kayo, Т., Sawada, Y., Suzuki, Y., Suda, M., Tanaka, S., Konda, 
Y., Miyazaki, J. and Takeuchi, Y. (1996) J. Biol. Chem. 271, 
10731-10737. 
Kayo, Т., Sawada, Y., Suda, M., Konda, Y., Izumi, Т., Tanaka, 
S., Shibata, H. and Takeuchi, T. (1997) Diabetes 46, 1296-1304. 
Kayo, Т., Konda, Y., Tanaka, S., Takata, K., Koizumi, A. and 
Takeuchi, T. (1996) Endocrinology 137, 5126-5134. 
Konda, Y., Yokota, H., Kayo, Т., Horiuchi, Т., Sugiyama, N., 
Tanaka, S., Takata, K. and Takeuchi, T. (1997) J. Clin. Invest. 
99, 1842-1851. 
Sawada, Y., Suda, M., Yokoyama, H., Kanda, Т., Sakamaki, Т., 
Tanaka, S., Nagai, R., Abe, S. and Takeuchi, T. (1997) J. Biol. 
Chem. 272, 20545-250554. 
Sawada, Y., Inoue, M., Kanda, Т., Sakamaki, Т., Tanaka, S., 
Minammo, N., Nagai, R. and Takeuchi, T. (1997) FEBS Lett. 
400, 177-182. 
Mivhalopoulos, G.K. and DeFrances, M.C. (1997) Science 276, 
60-66. 
Haber, B.A., Mohn, K.L., Diamond, R.H. and Taub, R. (1993) 
91, 1319-1326. 
Kogure, K., Ornata, W., Kanzaki, M., Zhang, Y., Yasuda, H., 
Mine, T. and Kojima, I. (1995) Gastroenterology 108, 1136-
1142. 
Yasuda, H., Mine, Т., Shibata, H., Eto, Y., Hasegawa, Y., Take-
uchi, Т., Asano, S. and Kojima, I. (1993) J. Clin. Invest. 92, 
1491-1496. 
Tsuji, Т., Okada, F., Yamaguchi, K. and Nakamura, T. (1990) 
Proc. Nati. Acad. Sci. USA 87, 8835-8839. 
Francavilla, A., Starai, Т.Е., Van Thiel, D.H., Barone, M. and 
Polimeno, L. (1993) in: Molecular and Cell Biology of the Liver, 
pp. 309-346. 
Dubois, СМ., Laprise, M., Blanchette, F., Gentry, L.E. and 
Ledue, R. (1995) J. Biol. Chem. 270, 10618-10624. 
Kiefer, M.C, Tucker, J.E., Joh, R., Landsberg, K.E., Saltman, 
D. and Berr, P.J. (1991) DNA Cell Biol. 10, 757-769. 
Massague, J. (1990) Annu. Rev. Cell. Biol. 6, 597-641. 
Taipale, J., Miyazono, K., Heldin, С and Keski-Oja, J. (1994) 
J. Cell. Biol. 124, 171-181. 
Obberghen-Schilling, E.V., Roche, N.S., Flanders, K.C., Sporn, 
M.B. and Roberts, A.B. (1988) J. Biol. Chem. 263, 7741-7746. 
Blanchette, F., Day, R., Dong, W., Laprise, M.-H. and Dubois, 
CM. (1997) J. Clin. Invest. 99, 1974-1983. 
Bissell, D.M., Wang, S., Jarnagin, W.R. and Joseph Roll, F. 
(1995) J. Clin. Invest. 96, 447^155. 
